Breakthrough treatments and clinical trials do not always mean new technology but entirely new applications of existing technology. Last year, the IBD Center at Columbia enrolled the first patient in a nationwide study using the established technique of sacral nerve stimulation (SNS) in a new way: to treat Crohn’s Disease and ulcerative colitis, or IBD. A disease that affects over 3.5 million people in the United States.
SNS is a type of electrical stimulation therapy that uses a small device implanted in a pocket under the skin to stimulate the sacral nerve with a series of daily electrical pulses. This triggers stimulation similar to acupuncture and can eliminate the need for medications in IBD management.
After completion of the early feasibility phase, the BOOM-IBD trial is gearing up for the pivotal study.
Click here to learn more about trial enrollment.
Enrollment Contact:
Call (212) 342-4102
Maeve D Bleistein: mb4971@cumc.columbia.edu
Claudia Musat, MD: cm2065@cumc.columbia.edu
Related:
- Groundbreaking Study for Treating IBD: Here’s What to Know About Sacral Nerve Stimulation
- What You Need To Know About Colorectal Cancer
- Dr. AI: What Is the Best Way to Treat Hemorrhoids?